C Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral Formulation

Author： Levy G.A.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.5, 2001-05, pp. : 279-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclosporin as Baseline Immunosuppression in Solid Organ Transplantation

By Winkler M.  

BioDrugs, Vol. 14, Iss. 3, 2000-09 ,pp. : 185-193

Adis International

Access to resources Recommend Favorite

Cyclosporin in Rheumatoid Arthritis: Monitoring for Adverse Effects and Clinically Significant Drug Interactions

By Dijkmans B.   Gerards A.  

BioDrugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 437-445

Adis International

Access to resources Recommend Favorite

Optimising endorphins

By Kirkham Mavis   Jowitt Margaret  

The Practising Midwife, Vol. 15, Iss. 10, 2012-11 ,pp. : 33-35

Medical Education Solutions Limited

Access to resources Recommend Favorite

Efficacy and Tolerability of Conversion from Cyclosporin to Azathioprine After Kidney Transplantation: A Review of the Evidence

By Hollander A.A.M.J.   van der Woude F.J.  

BioDrugs, Vol. 9, Iss. 3, 1998-03 ,pp. : 197-210

Adis International

Access to resources Recommend Favorite

Topical cyclosporin for atopic keratoconjunctivitis

By Kitnet Kwanpornsan  

International Journal of Evidence-based Healthcare, Vol. 11, Iss. 1, 2013-03 ,pp. : 84-84

Blackwell Publishing

Access to resources Recommend Favorite